Published in Lancet on December 16, 2000
Cloning, sequencing, and functional analysis of oriL, a herpes simplex virus type 1 origin of DNA synthesis. Mol Cell Biol (1985) 4.14
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis (2010) 1.73
AMD3100 for urgent PBSC mobilization and allogeneic transplantation from a normal donor after failed marrow harvest. Bone Marrow Transplant (2010) 1.46
Systemic sclerosis and multiple sclerosis. J Neurol (1999) 1.45
Interleukin-6 and soluble interleukin-2 receptor in juvenile chronic arthritis: correlations with clinical and laboratory parameters. Rev Rhum Engl Ed (1996) 1.38
Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis (2010) 1.22
Stringency without ppGpp accumulation. Nature (1981) 1.22
Diastolic function abnormalities in rheumatoid arthritis. Evaluation By echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease. Ann Rheum Dis (2000) 1.21
NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Ann Rheum Dis (2010) 1.19
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy. Rheumatology (Oxford) (2008) 1.12
Bioadhesive microspheres for ophthalmic administration of acyclovir. J Pharm Pharmacol (1997) 1.06
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann Rheum Dis (2011) 1.05
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis (2010) 1.05
Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities. Clin Rheumatol (2003) 1.04
Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13. Ann Rheum Dis (2002) 0.99
Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study. Clin Exp Rheumatol (1996) 0.99
Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis. Arthritis Rheum (2011) 0.98
Focal lymphocytic aggregates in chronic hepatitis C: occurrence, immunohistochemical characterization, and relation to markers of autoimmunity. Hepatology (1995) 0.98
Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C. Aliment Pharmacol Ther (2002) 0.97
Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype. Arthritis Rheum (2011) 0.96
Appearance of rheumatoid nodules following anti-tumor necrosis factor alpha treatment with adalimumab for rheumatoid arthritis. Clin Exp Rheumatol (2007) 0.94
Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population. Arthritis Rheum (2010) 0.94
Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis. Ann Rheum Dis (2008) 0.91
Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation. Clin Exp Immunol (2015) 0.90
Caspase-3 activation in human melanoma A375 cell line by a novel selective sigma-2 agonist. Pharmazie (2016) 0.90
Relationship of interleukin-12 and interleukin-13 imbalance with class-specific rheumatoid factors and anticardiolipin antibodies in systemic lupus erythematosus. Clin Rheumatol (2003) 0.87
Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: effect of treatment with recombinant alpha interferon. Hepatogastroenterology (1997) 0.87
Nailfold capillaroscopy changes in systemic lupus erythematosus: correlations with disease activity and autoantibody profile. Lupus (2005) 0.86
High prevalence of capillary abnormalities in patients with diabetes and association with retinopathy. Diabet Med (2011) 0.85
Relationship of soluble interleukin-2-receptor and interleukin-6 with class-specific rheumatoid factors during low-dose methotrexate treatment in rheumatoid arthritis. Rev Rhum Engl Ed (1997) 0.85
Autonomic dysfunction and neuropeptide Y in fibromyalgia. Clin Exp Rheumatol (2010) 0.85
Hepatitis C virus infection of salivary gland epithelial cells. Lack of evidence. J Hepatol (1997) 0.85
Co-occurrence of psoriatic arthritis with collagenous colitis: clinicopathologic findings of a case. Clin Rheumatol (2002) 0.85
Comparison of the Health Assessment Questionnaire and Arthritis Impact Measurement Scale in patients with psoriatic arthritis. Rev Rhum Engl Ed (1998) 0.84
Prevalence of anti-HCV antibodies in patients with chronic liver disease and its relationship to HBV and HDV infections. Infection (1991) 0.84
Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study. Ann Rheum Dis (2008) 0.84
Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile. Clin Exp Rheumatol (2002) 0.84
Anti-cyclic citrullinated peptide antibody determination in synovial fluid of psoriatic arthritis. Clin Exp Rheumatol (2007) 0.84
Osteopathic manipulative treatment (OMT) effects on mandibular kinetics: kinesiographic study. Eur J Paediatr Dent (2008) 0.83
Long-term follow-up of low-dose methotrexate therapy in one case of idiopathic retroperitoneal fibrosis. Clin Rheumatol (1995) 0.83
Visual input effect on EMG activity of masticatory and postural muscles in healthy and in myopic children. Eur J Paediatr Dent (2006) 0.83
Interleukin 13 in synovial fluid and serum of patients with psoriatic arthritis. Ann Rheum Dis (2002) 0.83
More severe nailfold capillaroscopy findings and anti-endothelial cell antibodies. Are they useful tools for prognostic use in systemic sclerosis? Clin Exp Rheumatol (2009) 0.82
Correlations between peripheral and axial radiological changes in patients with psoriatic polyarthritis. Rev Rhum Engl Ed (1996) 0.82
Interleukin-6 and soluble interleukin-2-receptor in psoriatic arthritis: correlations with clinical and laboratory parameters. Clin Exp Rheumatol (1997) 0.82
A transbasisphenoidal approach for selective occlusion of the middle cerebral artery in rats. Experientia (1980) 0.82
[Chyliform effusions in rheumatoid arthritis. Cytochemical and ultrastructural studies of the foam cells]. Rev Rhum Mal Osteoartic (1981) 0.81
Antibodies to hepatitis A virus in Italian patients with chronic liver disease. Epidemiol Infect (2001) 0.81
Adhesion molecule expression in the synovial membrane of psoriatic arthritis. Ann Rheum Dis (2002) 0.81
Ultrasound transmission velocity of the proximal phalanxes of the non-dominant hand in the study of osteoporosis. Clin Rheumatol (1997) 0.81
Assessment of subclinical atherosclerosis in ankylosing spondylitis: correlations with disease activity indices. Reumatismo (2013) 0.80
Sternoclavicular joint disease in psoriatic arthritis. Ann Rheum Dis (1992) 0.80
[Value of synovial biopsy in the diagnosis of arthropathies associated with hyperlipoproteinemias]. Rev Rhum Mal Osteoartic (1980) 0.80
Prevalence of astigmatism in a paediatric population with malocclusions. Eur J Paediatr Dent (2011) 0.80
A case of relapsing polychondritis: pathogenetic considerations. Clin Exp Rheumatol (1988) 0.80
Synthesis, physical properties, toxicological studies and bioavailability of L-pyroglutamic and L-glutamic acid esters of paracetamol as potentially useful prodrugs. J Pharm Pharmacol (1996) 0.80
Current practice of chronic hepatitis B treatment in Southern Italy. Eur J Intern Med (2012) 0.79
Intracellular accumulation of ofloxacin-loaded liposomes in human synovial fibroblasts. Antimicrob Agents Chemother (1995) 0.79
Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis. Clin Exp Rheumatol (2007) 0.79
Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian study. Clin Exp Rheumatol (2008) 0.79
Prevalence of atypical swallowing: a kinesiographic study. Eur J Paediatr Dent (2006) 0.79
Prevalence of hyperopia and strabismus in a paediatric population with malocclusions. Eur J Paediatr Dent (2011) 0.79
Comparison of ultrasound transmission velocity with computed metacarpal radiogrammetry and dual-photon absorptiometry. Eur Radiol (1996) 0.79
[Usefulness of anti-cyclic citrullinate peptide antibody determination in synovial fluid analysis of patients with rheumatoid arthritis]. Reumatismo (2006) 0.78
One year treatment with low dose methotrexate in rheumatoid arthritis: effect on class specific rheumatoid factors. Clin Rheumatol (1993) 0.78
Anti-endothelial cell antibodies in rheumatic heart disease. Clin Exp Immunol (2010) 0.78
Effects of myogenous facial pain on muscle activity of head and neck. Int J Oral Maxillofac Surg (2010) 0.78
Life-table analysis of cyclosporin A treatment in psoriatic arthritis: comparison with other disease-modifying antirheumatic drugs. Clin Exp Rheumatol (1998) 0.78
The radiological assessment of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the modified SASSS scoring methods. Clin Exp Rheumatol (2010) 0.78
Paramedian hourglass epidermoid extending above and below the tentorium. Surg Neurol (1982) 0.78
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs. Reumatismo (2014) 0.78
Pharmacological evaluation of anti-inflammatory pyrrole-acetic acid derivative eye drops. J Ocul Pharmacol Ther (1997) 0.78
[Italian consensus on Eular 2003 recommendations for the treatment of knee osteoarthritis]. Reumatismo (2004) 0.78
High serum resistin in chronic viral hepatitis is not a marker of metabolic disorder. Hepatogastroenterology (2011) 0.78